Newsroom
Sorted by: Latest
-
Sofinnova Partners schließt Sofinnova Capital XI mit 650 Mio. € (750 Mio. $) und übertrifft damit deutlich das ursprüngliche Ziel
PARIS--(BUSINESS WIRE)--Sofinnova Partners (“Sofinnova"), eine führende europäische Venture-Capital-Gesellschaft im Bereich Life Sciences mit Büros in Paris, London und Mailand, gibt den erfolgreichen Abschluss ihres neuesten Flaggschifffonds Sofinnova Capital XI mit einem Volumen von 650 Millionen Euro (750 Millionen US-Dollar) bekannt – und übertrifft damit das ursprünglich anvisierte Ziel deutlich. Mit dem Fonds unterstützt Sofinnova die naechste Generation wegweisender biopharmazeutischer u...
-
Sofinnova Partners supera il target e raccoglie 650 milioni di euro per accelerare la prossima generazione di start-up biotecnologiche con il fondo Capital XI
PARIGI--(BUSINESS WIRE)--Sofinnova Partners ("Sofinnova"), una delle principali società europee di venture capital nel settore delle scienze della vita con sedi a Parigi, Londra e Milano, ha annunciato oggi la chiusura della raccolta del suo fondo di punta, Sofinnova Capital XI, a 650 milioni di euro (750 milioni di dollari), superando ampiamente l’obiettivo iniziale. Sofinnova Capital XI sosterrà una nuova generazione di aziende biofarmaceutiche e di tecnologie mediche pionieristiche, impegnat...
-
Sofinnova Partners clôt son fonds Capital XI à 650 M€ (750 M$), largement au-dessus de son objectif, pour soutenir les entreprises early-stage dans la santé
PARIS--(BUSINESS WIRE)--Sofinnova Partners (“Sofinnova"), un leader du capital-risque en Europe spécialisé dans les sciences de la vie et basé à Paris, Londres et Milan, annonce aujourd’hui la clôture finale de son fonds amiral, Sofinnova Capital XI, à 650 millions d’euros (750 millions de dollars), dépassant largement son objectif initial. Sofinnova Capital XI investira dans la nouvelle génération d’entreprises de biopharmacie et d’instrumentation médicale, ciblant des besoins cliniques essent...
-
Sofinnova Partners Closes €650M ($750M) Capital XI, Greatly Exceeding Initial Target to Back Early-Stage Healthcare Deals
PARIS--(BUSINESS WIRE)--Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the close of its latest flagship fund, Sofinnova Capital XI, at €650 million ($750 million), greatly exceeding its initial target. Sofinnova Capital XI will back a new generation of pioneering biopharmaceutical and medical technology companies addressing urgent unmet clinical needs. In keeping with Sofinnova’s multi-strategy platform...
-
Farmers Bancorp Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of The Farmers Bancorp, Frankfort, Indiana - FABP
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of The Farmers Bancorp, Frankfort, Indiana (OTC: FABP) to Richmond Mutual Bancorporation, Inc. (NasdaqCM: RMBI). Under the terms of the proposed transaction, shareholders of Farmers will receive 3.40 shares of Richmond Mutual for each share of Farmers that they own. KSF is seeking to determine whether...
-
Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cidara Therapeutics, Inc. (NasdaqCM: CDTX) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Cidara will receive $221.50 in cash for each share of Cidara that they own. KSF is seeking to determine whether this consideration and the process that l...
-
Alibaba (BABA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Alibaba Group Holding Ltd. (“Alibaba” or the “Company”) (NYSE: BABA) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALIBABA (BABA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at...
-
Rio Tinto partners with Calix to test low-emissions steel making in Western Australia, pauses BioIron
PERTH, Australia--(BUSINESS WIRE)--Rio Tinto has signed a Joint Development Agreement (JDA) with Australian environmental technology company Calix to support construction of Calix’s Zero Emissions Steel Technology (Zesty™) demonstration plant in Western Australia, which could enable Pilbara iron ores to be used in lower-emissions steel making. If approved, the demonstration plant will be built at a site in Kwinana, south of Perth, that had been earmarked for Rio Tinto’s previously announced Bio...
-
NJDCY Investors Have Opportunity to Join Nidec Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--NJDCY Investors Have Opportunity to Join Nidec Corporation Fraud Investigation with the Schall Law Firm...
-
HRL Investors Have Opportunity to Join Hormel Foods Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--HRL Investors Have Opportunity to Join Hormel Foods Corporation Fraud Investigation with the Schall Law Firm...